Skip to main content
Year archive

CYCLOPHARM LIMITED — 2016 filings

All 33 regulatory filings released by CYCLOPHARM LIMITED (CYC) in 2016, sourced directly from the official regulator.

33 Filings
2016 Period
2016 filings (33)
Filing Released Lang
Change of Director's Interest Notice 3 pages 109.0KB
Director's Dealing
2016-11-24 English
CYC Achieves USFDA Agreement For Technegas Trial Design 2 pages 129.6KB
Regulatory Filings
2016-11-22 English
Change of Company Address 1 page 127.3KB
Regulatory Filings
2016-10-30 English
Cyclopharm CEO Microcap Investment Conference Presentation 28 pages 823.8KB
Investor Presentation
2016-10-18 English
Cyclopharm Business Update on Significant Milestones 3 pages 148.3KB
Capital/Financing Update
2016-10-12 English
Chairman to Stand Down Temporarily 1 page 240.0KB
Board/Management Information
2016-10-06 English
CYC Share Registry Details 1 page 235.7KB
Regulatory Filings
2016-08-28 English
Cyclopharm Limited 1H2016 Results Investor Presentation 28 pages 739.5KB
Investor Presentation
2016-08-23 English
Appendix 4D and Half Year Accounts 47 pages 2.1MB
Interim / Quarterly Report H1 2016
2016-08-18 English
Dividend/Distribution - CYC 3 pages 26.5KB
Notice of Dividend Amount
2016-08-18 English
CEO Presentation at BioShares BioTech Summit 2016 12 pages 346.7KB
Investor Presentation
2016-07-28 English
Appendix 3B LTIP 12 pages 677.8KB
Capital/Financing Update
2016-07-25 English
Cyclopharm Investor Presentation 21 July 2016 27 pages 741.8KB
Interim / Quarterly Report H1 2016
2016-07-20 English
CYC Strengthens Mgt Depth and Expands Clinical Expertise 2 pages 396.0KB
Board/Management Information
2016-07-13 English
Change of Director's Interest Notice 2 pages 239.7KB
Director's Dealing
2016-06-27 English
Change of Director's Interest Notice 2 pages 254.5KB
Director's Dealing
2016-06-27 English
CYC Signs Agreement with the Canadian Association of Nuc Med 2 pages 561.9KB
Regulatory Filings
2016-06-26 English
Trading Update & Record Technegas Order Received from China 3 pages 332.9KB
Interim / Quarterly Report H1 2016
2016-06-20 English
Chairman's Address to Shareholders 4 pages 372.8KB
AGM Information
2016-05-10 English
Managing Director's AGM Presentation 29 pages 1.1MB
AGM Information
2016-05-10 English
Managing Director's Report 6 pages 342.0KB
Investor Presentation
2016-05-10 English
Results of Annual General Meeting 2 pages 229.2KB
Declaration of Voting Results & Voting Rights Announcements
2016-05-10 English
Board Changes / Appendix 3Z 4 pages 481.1KB
Board/Management Information
2016-05-10 English
Announcement of buy-back - Appendix 3C 3 pages 227.3KB
Transaction in Own Shares
2016-05-10 English
Cyclopharm to Proceed Independently with FDA Trials 2 pages 156.5KB
Capital/Financing Update
2016-05-09 English
Appendix 4G 10 pages 228.2KB
Governance Information
2016-04-17 English
Notice of Annual General Meeting/Proxy Form 18 pages 394.7KB
AGM Information
2016-04-07 English
Annual Report to shareholders 104 pages 1.5MB
Annual Report FY 2015
2016-03-16 English
Cyclopharm Limited Investor Presentation 37 pages 1.7MB
Annual Report FY 2015
2016-03-16 English
Preliminary Final Report 63 pages 1.1MB
Annual Report FY 2015
2016-02-23 English
Strong Technegas Earnings Underpin Record Profit 3 pages 96.5KB
Annual Report FY 2015
2016-02-23 English
Dividend/Distribution - CYC 3 pages 26.5KB
Notice of Dividend Amount
2016-02-23 English
Technegas COPD Trial Update 2 pages 290.0KB
Regulatory Filings
2016-01-28 English